Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.600
+0.010 (0.28%)
At close: Jun 3, 2026, 4:00 PM EDT
3.551
-0.049 (-1.35%)
After-hours: Jun 3, 2026, 6:17 PM EDT
Voyager Therapeutics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Voyager Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $14.89. The average 1-year stock price forecast is 313.61% higher than the current stock price, while the lowest is $8.00 (+122.22%) and the highest is $25 (+594.44%).
Price Target: $14.89 (+313.61%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +594.44% | May 26, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +122.22% | May 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $12 | Buy | Reiterates | $12 | +233.33% | May 11, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $18 | Buy | Maintains | $18 | +400.00% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
43.53M
from 40.37M
Increased by 7.82%
Revenue Next Year
61.69M
from 43.53M
Increased by 41.71%
EPS This Year
-1.61
from -2.04
EPS Next Year
-1.48
from -1.61
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 125.7M | ||
| Avg | 43.5M | ||
| Low | 9.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 211.2% | ||
| Avg | 7.8% | ||
| Low | -77.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.71 | ||
| Avg | -1.61 | ||
| Low | -1.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.